Extracellular vesicles conjugated with c(RGDyk) peptide targeting integrin αVβ3 repair optic nerve injury through YAP/TAZ and Smad2/3 signaling
Stem Cells Translational Medicine · 2026
DOI: 10.1093/stcltm/szag006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Mira Park und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Extracellular Vesicles, Integrin alphaVbeta3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Extracellular vesicles (EVs) derived from mesenchymal stem cells have therapeutic potential for optic nerve injury. However, further investigations are needed to increase their efficacy. In this study, we tried to enhance targeting and recovery function of EVs using conjugation with integrin αVβ3 antagonist-c(RGDyk) peptide. The molecular mechanism of neuronal repair was investigated as a potential treatment for optic nerve injury. EVs were shown to restore effectively the abnormal regulations of neuronal markers in optic nerve injury models. Notably, the functionally optimized c(RGDyK)_EVs exhibited superior targeting capabilities and modulated neuroregeneration in cases of hypoxic damage and inflammation. Single-cell RNA-seq analysis of R28 cells revealed significant regulation of transcription of genes involved in retinal ganglion cell (RGC) regeneration, neuronal growth, and inflammation by c(RGDyK)_EVs via the Yap-Taz signaling pathway. This study highlighted the enhanced therapeutic potential of c(RGDyK)_EVs over naïve EVs in the context of optic nerve disease. The findings suggested that c(RGDyK)_EVs hold promise as an alternative therapy for optic nerve injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam, Gyeonggi-do, 13496, Republic of Korea.
- Department of Biomedical Science, CHA University, Seongnam, Gyeonggi-do, 13488, Republic of Korea.
- CHA Advanced Research Institute., R&D Support Center, CHA University, Seongnam, Gyeonggi-do, 13488, Republic of Korea.
- ORANDBIO Co., Ltd., Uiwang-si, Gyeonggi-do, 16018, Republic of Korea.
ORCID-Profile: Helen Lew
Förderung
- National Research Foundation of Korea
Zitieren
APA
Park, M., Shin, H. A., Lee, H. J., Moon, J. H., Kim, J. Y., Rhim, W. K., Han, D. K., & Lew, H. (2026). Extracellular vesicles conjugated with c(RGDyk) peptide targeting integrin αVβ3 repair optic nerve injury through YAP/TAZ and Smad2/3 signaling. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag006
Vancouver
Park M, Shin HA, Lee HJ, Moon JH, Kim JY, Rhim WK, et al. Extracellular vesicles conjugated with c(RGDyk) peptide targeting integrin αVβ3 repair optic nerve injury through YAP/TAZ and Smad2/3 signaling. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szag006
BibTeX
@article{Park2026,
author = {Park, Mira and Shin, Hyun Ah and Lee, Hey Jin and Moon, Jong Hyun and Kim, Jun Yong and Rhim, Won-Kyu and Han, Dong Keun and Lew, Helen},
title = {Extracellular vesicles conjugated with c(RGDyk) peptide targeting integrin αVβ3 repair optic nerve injury through YAP/TAZ and Smad2/3 signaling},
journal = {Stem Cells Translational Medicine},
year = {2026},
doi = {10.1093/stcltm/szag006}
}
EUVIMED